On the Bright Side, page-49

First 49 Last

Share
Profile

Follow
Beale

3,673 Posts.

657

25/06/16

17:16

Post #: 18123147
Share

Originally posted by Augment ↑

As a obviously naive long term holder of SUD I thought ( foolishly it seems) that a little honest and optimistic input into this
HC blog might boost morale with a bit of input.
But for some I am a liar, an IT claiming I know more than anyone else and basically full of s--t.
For those interested I get my information from research, comparisons and frequently asking many, many probing questions of the company management. Once I believe I have some knowledge I pass this on to other frustrated investors on this blog, to be useful and hopefully honest. But the information is my opinion and I believe logical thought.
There is no information I give that is not available to any of you who read and evaluate the announcements, watch webinar presentations, go to the AGM's and follow other similar Biotechs and their often long and painful histories. Some do spectacularly well and others fall by the wayside.
Logic plays an important part combined with announcements from the company, leading me to certain assumptions about prospective partners, etc.
For example it has been stated many times that the company is in late stage negotiations with 3 of the the top 5 major pharma.
Its not rocket science to work out that SUD-003 ( *word disallowed by google) would be a great match for Pfizer, as their Viagra patent lapses in 2020.( notwithstanding a deal they have done with TEVA to manufacture generics). Pfizer to me is the logical major pharma who may be looking at SUD-003 as a new and rapid acting form of Viagra. Why wouldn't they look at a cheap alternative? But of course they need the data to be comprehensive and prove that the absorption profile of a new formula is worth buying into! Thus the in vivo rabbit study taking place. If the results are good then perhaps Pfizer might buy that formula from SUDA? Thats my logical guess and not from any other information base.
Again ArtiMIST is moving , as can be seen by the announcements. Novartis are a major pharma who are selling Artemether drugs for subSaharan African malaria, and would be a very good fit to buy into ArtiMist. To me thats logical??
I suggest anyone who is able to speak to NW or SC should go to the office and ask as many questions as you want, as a SH,which is your right. It may even be worth catching a plane if able as this is better than a phone call.
The management can only give you an indication of whats happening, but with enough questions you may get a broader understanding of where things are at in negotiations.
All this seems more effective than repeating the "same old "on HC and accusing others of various things.

Thats me on HC for the time being. And yes I hope to buy a small parcel of SUD shares next week as I believe we're onto a frustrating, but 'good thing.'

Expand

Don't go missing just because of some of the fwits that live on here aug. I like your posts. There's only one reason none of them go away either. One thing I must say.....could be wrong but I've got Merck all over artimist! Not novartis!! Happy days coming !!

Last edited by Beale: 25/06/16

SUD Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

GMD

Genesis set for higher gold production in FY25 and earlier mill start

TAT

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

BAS

Bass completes successful testing work at Kiwi-1, showing higher-than-expected condensate yields

RDN

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

EMD

Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA

There are more pages in this discussion • 9 more messages in this thread...

First 49 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 14.5¢		Change 0.000(0.00%)		Mkt cap ! $157.7M

Open	High	Low	Value	Volume
15.0¢	15.0¢	14.5¢	$160.3K	1.094M

Buyers (Bids)

No.	Vol.	Price($)
14	433582	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
14.5¢	320274	6

View Market Depth

No.	Vol.	Price($)
14	433582	0.140
15	509132	0.135
10	759615	0.130
8	431775	0.125
7	430855	0.120

Price($)	Vol.	No.
0.145	320274	6
0.150	250774	8
0.155	276545	7
0.160	494733	8
0.165	252123	5

Last trade - 11.57am 02/09/2024 (20 minute delay)

ALA (ASX) Chart

On the Bright Side, page-49

Genesis set for higher gold production in FY25 and earlier mill start

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Bass completes successful testing work at Kiwi-1, showing higher-than-expected condensate yields

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

On the Bright Side, page-49

Top Stories

Genesis set for higher gold production in FY25 and earlier mill start

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Bass completes successful testing work at Kiwi-1, showing higher-than-expected condensate yields

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News